Twice‐daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice‐daily omeprazole, rabeprazole or lansoprazole S Sahara, M Sugimoto, T Uotani, H Ichikawa, M Yamade, M Iwaizumi, ... Alimentary pharmacology & therapeutics 38 (9), 1129-1137, 2013 | 97 | 2013 |
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin‐based triple therapy T Furuta, M Sugimoto, M Yamade, T Uotani, S Sahara, H Ichikawa, ... The Journal of Clinical Pharmacology 54 (3), 258-266, 2014 | 61 | 2014 |
Guggulsterone and its role in chronic diseases T Yamada, K Sugimoto Drug discovery from mother nature, 329-361, 2016 | 60 | 2016 |
Sitafloxacin‐based third‐line rescue regimens for Helicobacter pylori infection in Japan T Furuta, M Sugimoto, C Kodaira, M Nishino, M Yamade, T Uotani, ... Journal of Gastroenterology and Hepatology 29 (3), 487-493, 2014 | 46 | 2014 |
Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype T Uotani, M Sugimoto, M Nishino, C Kodaira, M Yamade, S Sahara, ... Clinical Gastroenterology and Hepatology 10 (8), 879-885. e2, 2012 | 41 | 2012 |
Eradication of H. pylori infection in patients allergic to penicillin using triple therapy with a PPI, metronidazole and sitafloxacin T Furuta, M Sugimoto, M Yamade, T Uotani, S Sahara, H Ichikawa, ... Internal Medicine 53 (6), 571-575, 2014 | 37 | 2014 |
Norepinephrine suppresses IFN-γ and TNF-α production by murine intestinal intraepithelial lymphocytes via the β1 adrenoceptor Y Takayanagi, S Osawa, M Ikuma, K Takagaki, J Zhang, Y Hamaya, ... Journal of neuroimmunology 245 (1-2), 66-74, 2012 | 33 | 2012 |
Cytokine responses of intraepithelial lymphocytes are regulated by histamine H2 receptor K Takagaki, S Osawa, Y Horio, T Yamada, Y Hamaya, Y Takayanagi, ... Journal of gastroenterology 44, 285-296, 2009 | 27 | 2009 |
Guggulsterone, a plant-derived inhibitor of NF-TB, suppresses CDX2 and COX-2 expression and reduces the viability of esophageal adenocarcinoma cells T Yamada, S Osawa, M Ikuma, M Kajimura, M Sugimoto, T Furuta, ... Digestion 90 (3), 208-217, 2014 | 24 | 2014 |
Lymphomatoidgastropathy mimicking extranodal NK/T cell lymphoma, nasal type: a case report T Terai, M Sugimoto, H Uozaki, T Kitagawa, M Kinoshita, S Baba, ... World Journal of Gastroenterology: WJG 18 (17), 2140, 2012 | 24 | 2012 |
Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma S Osawa, T Furuta, K Sugimoto, T Kosugi, T Terai, M Yamade, ... Bmc Cancer 9, 1-10, 2009 | 23 | 2009 |
A case of small bowel adenocarcinoma in a patient with Crohn’s disease detected by PET/CT and double-balloon enteroscopy C Kodaira, S Osawa, C Mochizuki, Y Sato, M Nishino, T Yamada, ... World Journal of Gastroenterology: WJG 15 (14), 1774, 2009 | 23 | 2009 |
Statins directly suppress cytokine production in murine intraepithelial lymphocytes J Zhang, S Osawa, Y Takayanagi, M Ikuma, T Yamada, M Sugimoto, ... Cytokine 61 (2), 540-545, 2013 | 22 | 2013 |
Cecal vanishing tumor associated with cytomegalovirus infection in an immunocompetent elderly adult S Kawasaki, S Osawa, K Sugimoto, T Uotani, M Nishino, T Yamada, ... World Journal of Gastrointestinal Oncology 2 (11), 417, 2010 | 19 | 2010 |
Guggulsterone suppresses bile acid-induced and constitutive caudal-related homeobox 2 expression in gut-derived adenocarcinoma cells T Yamada, S Osawa, Y Hamaya, T Furuta, A Hishida, M Kajimura, ... Anticancer research 30 (6), 1953-1960, 2010 | 19 | 2010 |
Influence of Prostate Stem Cell Antigen Gene Polymorphisms on Susceptibility to Helicobacter pylori‐associated Diseases: A Case‐control Study H Ichikawa, M Sugimoto, T Uotani, S Sahara, M Yamade, M Iwaizumi, ... Helicobacter 20 (2), 106-113, 2015 | 18 | 2015 |
Rapid automated genotyping of CYP2C19 and Helicobacter pylori 23S rRNA gene in gastric juice T Furuta J Gastroenterol Hepatol Res 2, 506, 2013 | 15 | 2013 |
Acid suppressive therapy improved symptoms due to circumferential cervical inlet patch with proton pumps (H+/K+-ATPase) T Yamada, A Tsuji, S Onoue, M Kaneko, F Tanioka, S Osawa, Y Saida World Journal of Clinical Cases 5 (11), 403, 2017 | 13 | 2017 |
Antiplatelet drugs are a risk factor for esophageal mucosal injury M Sugimoto, T Uotani, M Nishino, M Yamade, S Sahara, T Yamada, ... Digestion 87 (4), 281-289, 2013 | 13 | 2013 |
Trastuzumab has opposing effects on SN-38-induced double-strand breaks and cytotoxicity in HER2-positive gastric cancer cells depending on administration sequence M Yamade, M Sugimoto, M Nishino, T Uotani, S Sahara, M Iwaizumi, ... Anticancer research 32 (1), 105-114, 2012 | 13 | 2012 |